STUB1 and coronary artery disorder: Strong evidence suggests that CHIP carriers face a 1.9-fold higher risk (95% CI, 1.4–2.7) of coronary artery disease compared to non-carriers, along with a 4.0-fold elevated risk (95% CI, 2.4–6.7) for early-onset myocardial infarction [28].